McKesson has raised $1.7 billion in a sale of senior unsecured notes in three parts, The Wall Street Journal reports. The medical records and billing specialist appointed Bank of America Merrill Lynch and JP Morgan as the joint bookrunning managers for the deal. The $600 million notes sold in the first tranche are due to mature on March 1, 2016, while the $600 million notes sold in the second tranche are due to mature on March 1, 2021. The $500 million notes sold in the third tranche will mature on March 1, 2041. The proceeds will be used by McKesson to repay borrowings on a bridge loan that it used in connection with a recent acquisition.
Click here for the story from The Wall Street Journal.
Click here for additional coverage from Reuters.